According to the report titled ‘Global Retinal Implants Market, 2021-2027’, available with MarketStudyReport, global retinal implants market is estimated to grow at 9% CAGR during the forecast period 2021-2027.

 

As per the report findings, rising prevalence of eye disorders and target disease, increase in the elderly population, and availability of procedures to restore visions are the driving factors for the growth of global retinal implants market.

 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/3706278/

 

Notably, retinal implants are used to help individuals who have either limited or absolute blindness in improving their vision. Retinal prosthetics has received greater prominence because of the ease with which the retina may be accessed for surgical purposes.

 

With more FDA approvals and large-scale clinical studies, alongside supportive reimbursement scenario, the market is set to flourish. Also, surge in government spending in healthcare sector, coupled with leading market participants taking numerous initiatives for marking their presence in unexplored regions will augment the industry outlook.

 

By product type, global retinal implants market is categorized into three types, namely, Argus II, Retina Implant Alpha-IMS, and Implantable Miniature Telescope (IMT). Insights pertaining to industry share held, revenue generated, and growth rate for each segment over the analysis timeframe are provided in the report.

 

From regional frame of reference, the market is analyzed across Asia-Pacific (Australia, Thailand, India, Indonesia, Taiwan, Japan, Korea, China), Middle East & Africa (Egypt, Israel, Iran, Turkey, Nigeria, South Africa, UAE, RoMEA), Europe (UK, France, Spain, Italy, Germany, RoE), North America (Mexico, U.S., Canada), South America (Argentina, Chile, Peru, Brazil, Venezuela, Colombia).

 

Some of the prominent players in the global retinal implants market include Visioncare Ophthalmic Technologies Inc., Pixium Vision S.A., Labtician Ophthalmics Inc., and Second Sight Medical Products Incorporation. While still in its infancy, there are substantial investment opportunities in ophthalmology research & development and technological advances, which can be exploited by industry players to enhance their revenue scope.